Top Markets
Coin of the day
Genomic Vision S.A. Genomic Vision S.A.

Genomic Vision S.A.

GV
Ранг среди акций #41547
Headquartered in Bagneux, France, and established in 2004, Genomic Vision S.A.... Headquartered in Bagneux, France, and established in 2004, Genomic Vision S.A. is a molecular diagnostics and technology company focused on developing sophisticated tools for analyzing individual DNA molecules. These innovations serve both scientific research and in vitro diagnostic purposes. A cornerstone of their offerings is the FiberVision molecular combing platform, which streamlines DNA analysis workflows. This platform integrates FiberComb, a system for stretching single DNA molecules onto vinyl silane glass, with a FiberVision scanner designed to acquire high-resolution images of entire coverslip surfaces automatically. The data is then processed by FiberStudio software, which detects hybridization signals, analyzes results, and generates reports. Supporting these systems, the company provides the FiberPrep DNA extraction kit, producing purified DNA for combing, alongside essential accessories such as custom-treated glass carriers and disposable DNA reservoirs. Genomic Vision also offers specialized FiberProbes, including "Genomic Morse Code" sets for detecting mutations associated with hereditary breast and ovarian cancer (BRCA), as well as for identifying and characterizing structural variations related to hereditary nonpolyposis colorectal cancer, particularly anomalies in the flanking regions of MMR genes. Additionally, their molecular combing services enable clients to validate planned gene editing events, identify substantial unintended modifications (exceeding 1 kilobase), and precisely quantify on-target versus off-target genetic changes. The company reinforces its position through strategic partnerships, including an alliance with Quest Diagnostics and development and research collaborations with La Timone Hospital and the Institut Pasteur, respectively.
Цена акции
$0.00196068
Последняя синхронизация: 2023-12-01
Рыночная капитализация
$16.64K
Изменение (1 день)
0.01%
Изменение (1 год)
0.00%
Страна
FR
Торговля Genomic Vision S.A. (GV)

Категория

цена GV с рыночной капитализацией B
Genomic Vision S.A. Genomic Vision S.A.
GV
$0.00196068
Рыночная капитализация Genomic Vision S.A.(GV)
Рыночная капитализация: $16.64K
По состоянию на August 2026 рыночная капитализация Genomic Vision S.A. составляет $16.64K. Согласно нашим данным, Genomic Vision S.A. занимает 41547th место среди самых ценных компаний мира по рыночной капитализации. Рыночная капитализация — это общая рыночная стоимость всех находящихся в обращении акций публичной компании и обычно используется для оценки ее стоимости.
История рыночной капитализации Genomic Vision S.A. с 2014 по 2026
GV по сравнению с пятеркой самых популярных stocks
Цена за GV Актив Б Рыночная капитализация B результаты
Genomic Vision S.A. Genomic Vision S.A.
$634,318 $16.64K
$5.383T +32,352,000,318.50%
Genomic Vision S.A. Genomic Vision S.A.
$521,206 $16.64K
$4.423T +26,582,945,946.58%
Genomic Vision S.A. Genomic Vision S.A.
$490,214 $16.64K
$4.160T +25,002,282,125.49%
Genomic Vision S.A. Genomic Vision S.A.
$431,647 $16.64K
$3.663T +22,015,203,999.28%
Genomic Vision S.A. Genomic Vision S.A.
$340,672 $16.64K
$2.891T +17,375,216,229.83%